Evidence map›Paper›PMID 40733053›Full record

ArticlePharmaceutics2025

Influence of the pH Synthesis of Fe

Bárbara Costa, Eurico Pereira, Vital C Ferreira-Filho, Ana Salomé Pires, Laura C J Pereira, Paula I P Soares, Maria Filomena Botelho, Fernando Mendes, Manuel P F Graça, Sílvia Soreto Teixeira

Abstract read
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Impact of CeOGels (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bárbara Costai3N, Physics Department, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0001-7626-0210
Eurico PereiraCoimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, Universidade de Coimbra, Pólo III-Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.ORCID 0000-0002-6532-2989
Vital C Ferreira-FilhoCentro de Ciências e Tecnologias Nucleares, C2TN, DECN, Instituto Superior Técnico, University of Lisbon, 2695-066 Bobadela, Portugal.ORCID 0009-0002-1493-5950
Ana Salomé PiresCoimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, Universidade de Coimbra, Pólo III-Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.ORCID 0000-0001-7994-4650
Laura C J PereiraCentro de Ciências e Tecnologias Nucleares, C2TN, DECN, Instituto Superior Técnico, University of Lisbon, 2695-066 Bobadela, Portugal.ORCID 0000-0002-8818-0039
Paula I P Soaresi3N/CENIMAT, Department of Materials Science, School of Science and Technology, Nova University of Lisbon, 2829-516 Caparica, Portugal.ORCID 0000-0002-4975-7480
Maria Filomena BotelhoCoimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, Universidade de Coimbra, Pólo III-Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.ORCID 0000-0001-7202-1650
Fernando MendesCoimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, Universidade de Coimbra, Pólo III-Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.ORCID 0000-0002-5205-8939
Manuel P F Graçai3N, Physics Department, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0002-6858-9507
Sílvia Soreto Teixeirai3N, Physics Department, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0003-4084-5764

Funding

FCT-Fundação para a Ciência e a Tecnologia 2021.05543.BDFCT-Fundação para a Ciência e a Tecnologia 2024.02558.BDFCT-Fundação para a Ciência e a Tecnologia PRT/BD/154845/2023
6 · The paper itself

Abstract

Nanotechnology, specifically magnetic nanoparticles (MNPs), is revolutionizing cancer treatment. Magnetic hyperthermia is a treatment that, using MNPs, can selectively kill cancer cells without causing damage to the surrounding tissues.

Indexed as

hydrothermal synthesismagnetic hyperthermiamagnetiteNaOHSAR

Identifiers

PMID40733053
PMCPMC12298310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.